Endoprosthesis for the treatment of type A aortic dissection

Original title: Application of Open Triple-Branch Aortic Arch Stent Graff for Acute Stanford Type A Aortic Dissection Reference: Fei Hua, et; al. Vascular Endovascular Surgery 47;2:109-14

Type A aortic dissection is a disease of high morbidity and mortality, especially in the early hours . Surgery is the treatment of choice but still have a significant complication rate .

We analyzed 34 patients with type A aortic dissection treated with branched stent for neck vessels ( Aortec Medical Technology Co Ltd , Beijing , China ) and were compared with 16 patients who underwent conventional surgery . No significant differences in baseline characteristics of both groups.

The procedure was performed under general anesthesia with median stereotomy, cardiopulmonary bypass , blood cardioplegia and deep hypothermia before implantation of the stent and its branches. The group that received stents had lower cardiopulmonary bypass time ( 186 ± 38 min . Versus 204 ± 47 min .), lower myocardial ischemic  time ( 101 ± 27 min . Versus 119 ± 30 min .) , shorter selective brain perfusion time ( 39 ± 11 min . Versus 46 ± 11 min . ) , as well as mechanical ventilation assistance  (19.9 ± 3.4 hours versus 20.4 ± 3.7 hours. ) And stay in intensive care (82.1 ± 11.2 hours. Versus  89.2 ± 13.1 hours.) During hospitalization 2 patients died, one required dialysis , 2 evolved with arm mobility impairments and one  presented consciousness disorders. At 9.6 months (2-24 months) follow-up , no patient died and only one had right arm motility difficulty  and required rehabilitation. Control tomography was performed in all patients witnessing a correct stent implantation with the preserved flow in the legs without significant leaks .

Conclusion:

This stent would be useful for those patients who require surgical reconstruction of the thoracic aorta , thus reducing the time of cardiopulmonary bypass from traditional surgery and potential complications thereof . 

Comment:

While this is a small population, indicates that it was possible to satisfactory solve, with this strategy favorably resolve such a complex disease , reducing surgical time and intensive areas and a good performance in the medium term. 

Courtesy by Dr Carlos Fava
Interventional Cardiologist
Favaloro Foundation
Buenos Aires – Argentina

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....